Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282.

PubWeight™: 1.94‹?› | Rank: Top 2%

🔗 View Article (PMID 11583197)

Published in Ann Oncol on August 01, 2001

Authors

R K Ramanathan1, A Cnaan, R G Hahn, P P Carbone, D G Haller

Author Affiliations

1: University of Pittsburgh Cancer Institute, Pennsylvania 15213, USA. ramanathanrk@msx.upmc.edu

Articles citing this

Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med (2011) 11.55

Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors. J Clin Oncol (2012) 3.36

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas (2010) 3.00

First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas. Cancer (2010) 2.74

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas. Br J Cancer (2006) 2.23

O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors. Clin Cancer Res (2009) 2.00

Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors. J Hematol Oncol (2011) 1.27

Multimodal management of neuroendocrine liver metastases. HPB (Oxford) (2010) 1.21

Biology and treatment of metastatic gastrointestinal neuroendocrine tumors. Gastrointest Cancer Res (2008) 1.16

A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors. Dig Dis Sci (2006) 1.09

Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors. Nat Clin Pract Oncol (2009) 0.96

Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2014) 0.94

A multimodal approach to the management of neuroendocrine tumour liver metastases. Int J Hepatol (2012) 0.94

Progress in the treatment of neuroendocrine tumors. Curr Oncol Rep (2009) 0.91

Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review. Int J Hepatol (2011) 0.90

A new era for the systemic therapy of neuroendocrine tumors. Oncologist (2012) 0.89

A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor. Cancer (2013) 0.84

Treatment of gastroenteropancreatic neuroendocrine tumors. Virchows Arch (2007) 0.83

Combination of Capecitabine and Oxaliplatin is an Effective Treatment Option for Advanced Neuroendocrine Tumors. Rare Tumors (2013) 0.80

Emerging therapies and latest development in the treatment of unresectable pancreatic neuroendocrine tumors: an update for clinicians. Therap Adv Gastroenterol (2013) 0.80

Safety and efficacy of sunitinib in patients with unresectable pancreatic neuroendocrine tumors. Clin Med Insights Oncol (2012) 0.79

Advances in the Treatment of Pancreatic Neuroendocrine Tumors (pNETs). Gastrointest Cancer Res (2013) 0.79

Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor. World J Gastroenterol (2014) 0.78

Systemic therapy for advanced pancreatic neuroendocrine tumors. Semin Oncol (2013) 0.78

Medical treatment of gastroenteropancreatic neuroendocrine tumors. Cancers (Basel) (2012) 0.78

Advances in the treatment of gastroenteropancreatic neuroendocrine tumors. Clin Exp Gastroenterol (2010) 0.78

Targeted therapy in advanced well-differentiated neuroendocrine tumors. Oncologist (2011) 0.77

Nonfunctional Pancreatic Neuroendocrine Tumors: Advances in Diagnosis, Management, and Controversies. Int Surg (2015) 0.76

Treatment of liver metastases in patients with neuroendocrine tumors of gastroesophageal and pancreatic origin. Int J Hepatol (2012) 0.76

Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas. World J Gastroenterol (2016) 0.75

An Overview on the Sequential Treatment of Pancreatic Neuroendocrine Tumors (pNETs). Rare Cancers Ther (2015) 0.75

Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors. Hematol Oncol Clin North Am (2015) 0.75

The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012. ISRN Hepatol (2013) 0.75

Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors. BMC Cancer (2016) 0.75

Gastroenteropancreatic neuroendocrine tumors: recommendations of Turkish multidisciplinary neuroendocrine tumor study group on diagnosis, treatment and follow-up. Arch Med Sci (2017) 0.75

Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas. Neoplasia (2017) 0.75

Articles by these authors

(truncated to the top 100)

Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81

FOUR RECENT INFLUENZA EPIDEMICS: AN EXPERIMENTAL STUDY. J Clin Invest (1940) 20.40

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med (2001) 18.77

Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res (1971) 13.16

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med (1990) 11.57

A LATENT VIRUS IN NORMAL MICE CAPABLE OF PRODUCING PNEUMONIA IN ITS NATURAL HOST. J Exp Med (1940) 8.58

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med (1998) 7.60

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med (2001) 7.59

Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) (1970) 5.98

Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol (2003) 5.71

An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA (1993) 5.43

Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med (2001) 5.22

Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med (1970) 5.03

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland. Cancer (1977) 4.95

Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med (1992) 4.33

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer (1981) 3.86

Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med (1995) 3.83

Assessment of response to therapy in advanced breast cancer. Br J Cancer (1977) 3.70

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med (1992) 3.54

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med (1994) 3.29

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol (1997) 3.04

Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med (1998) 2.95

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med (1986) 2.70

Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin Exp Res (2000) 2.39

A comparison of awake versus paralyzed tracheal intubation for infants with pyloric stenosis. Anesth Analg (1998) 2.38

Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med (1967) 2.38

Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med (1973) 2.30

Survival and complications in thalassemia. Ann N Y Acad Sci (2005) 2.25

Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med (1969) 2.13

Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974-1994. J Pediatr (1997) 2.13

Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol (1995) 2.02

Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. J Natl Cancer Inst (1990) 1.97

Adolescents' perceptions of factors affecting their decisions to seek health care. JAMA (1995) 1.89

Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest (1967) 1.88

Long term survival after pancreatic resection for pancreatic adenocarcinoma. Am J Gastroenterol (2001) 1.87

Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy. Neurology (2011) 1.86

Pseudomonas pneumonia. A retrospective study of 36 cases. Am J Med (1973) 1.83

Treatment of the patient with adenocarcinoma of unknown origin. Cancer (1972) 1.79

Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol (1994) 1.79

Cranial ultrasound prediction of disabling and nondisabling cerebral palsy at age two in a low birth weight population. Pediatrics (1995) 1.75

Pseudohyperkalemia due to release of potassium from white blood cells during clotting. N Engl J Med (1966) 1.73

Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res (1995) 1.72

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy. Cancer (1978) 1.71

Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. N Engl J Med (1981) 1.70

Malignant pulmonary neoplasms predisposing to spontaneous pneumothorax. Mayo Clin Proc (1973) 1.66

Volume kinetics of Ringer solution, dextran 70, and hypertonic saline in male volunteers. Anesthesiology (1997) 1.64

Summary of infectious complications occurring in patients with Hodgkin's disease. Cancer Res (1966) 1.62

Recovery of cytomegalovirus from adults with neoplastic disease. Ann Intern Med (1966) 1.58

Nicodermal patch adherence and its correlates. Drug Alcohol Depend (1999) 1.57

Obstetric ultrasound by family physicians. J Fam Pract (1992) 1.55

Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches. Arch Dis Child (2005) 1.55

Phase II evaluation of menogaril in patients with advanced hypernephroma. Invest New Drugs (1991) 1.53

Monitoring of TURP with ethanol. Lancet (1992) 1.53

Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy. J Clin Oncol (1993) 1.52

Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1. Am J Clin Pathol (1995) 1.50

Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancer. J Clin Oncol (2001) 1.50

Extrapulmonary small-cell carcinoma. A review of the literature with emphasis on therapy and outcome. Medicine (Baltimore) (1987) 1.50

Longitudinal evaluation of cardiopulmonary performance during exercise after bone marrow transplantation in children. J Pediatr (2000) 1.49

Adenocarcinoma of the esophagus and esophago-gastric junction: the effects of single and combined modalities on the survival and patterns of failure following treatment. Int J Radiat Oncol Biol Phys (1990) 1.48

Time course of increased haemodilution in hypotension induced by extradural anaesthesia. Br J Anaesth (1996) 1.45

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. J Clin Oncol (1987) 1.42

Hydroxyethyl starches and dextran during hip replacement surgery: effects on blood volume and coagulation. Acta Anaesthesiol Scand (2011) 1.42

Waiting for the definitive trial of hepatic arterial chemotherapy for colorectal cancer. J Clin Oncol (2000) 1.42

Progressive decrease in glucose clearance during surgery. Acta Anaesthesiol Scand (2006) 1.42

Fluid absorption and the long-term outcome after transcervical resection of the endometrium. Acta Obstet Gynecol Scand (1998) 1.39

TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol (2000) 1.38

Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer (1974) 1.37

Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med (1980) 1.37

Looking beyond the physical injury: posttraumatic stress disorder in children and parents after pediatric traffic injury. Pediatrics (1999) 1.34

Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survival. JAMA (1966) 1.34

Cancer treatment and age: patient perspectives. J Natl Cancer Inst (1993) 1.34

Special report. Steriod receptors in breast cancer. N Engl J Med (1979) 1.33

Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Proc Natl Acad Sci U S A (2000) 1.33

Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A. J Natl Cancer Inst (1972) 1.32

Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine. J Natl Cancer Inst (1975) 1.32

Visual assessment of jaundice in term and late preterm infants. Arch Dis Child Fetal Neonatal Ed (2009) 1.31

Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys (1991) 1.30

Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys (1998) 1.29

Treatment of Burkitt's tumor with cyclophosphamide. Cancer (1970) 1.29

L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med (1969) 1.29

In vitro growth of normal and leukemic human bone marrow. J Natl Cancer Inst (1971) 1.27

Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. Drug Alcohol Depend (2001) 1.27

Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). Blood (1968) 1.26

Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease. Cancer (1971) 1.25

Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer. Cancer Chemother Rep (1975) 1.25

Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients. Am J Med (1967) 1.25

Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel. Cancer Chemother Rep (1974) 1.24

Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Ann Surg (1998) 1.22

Frequency of carriers of chronic (type I) Gaucher disease in Ashkenazi Jews. Am J Med Genet (1987) 1.22

Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification. Oncogene (2007) 1.21

Symptoms of the transurethral resection syndrome using glycine as the irrigant. J Urol (1995) 1.20

Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor. J Clin Oncol (2001) 1.20

Hidden spears: handlebars as injury hazards to children. Pediatrics (1998) 1.19

Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma. Cancer (1989) 1.18

High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas. Cancer Res (1997) 1.17

Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. Cancer Res (1968) 1.16

Prognostic factors for survival in hepatocellular carcinoma. Cancer Res (1988) 1.16

Elevated substance P levels in HIV-infected men. AIDS (2001) 1.16

Central nervous system involvement in Burkitt's lymphoma. Blood (1970) 1.16

The health consequences of smoking. Cancer. Med Clin North Am (1992) 1.15